aluates Reports

$ 0.0

Automative

Global Antibody-drug Conjugates Market Insights, Forecast to 2030

Published Date: June 2024

Report Code: QYRE-Auto-31N9042

Global Antibody drug Conjugates Market Insights and Forecast to 2028

BUY CHAPTERS

Global Antibody-drug Conjugates Market Insights, Forecast to 2030

Code: QYRE-Auto-31N9042

Report

June 2024

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Antibody-drug Conjugates Market Size

The global Antibody-drug Conjugates market is projected to grow from US$ 2975.7 million in 2024 to US$ 3919.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period.

Antibody-drug Conjugates Market

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

Report Covers:

This report presents an overview of global market for Antibody-drug Conjugates, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antibody-drug Conjugates, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antibody-drug Conjugates, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody-drug Conjugates sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody-drug Conjugates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Antibody-drug Conjugates sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Antibody-drug Conjugates Market Report

Report Metric	Details
Report Name	Antibody-drug Conjugates Market
Accounted market size in 2024	US$ 2975.7 million
Forecasted market size in 2030	US$ 3919.8 million
CAGR	4.7
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Adcetris Kadcyla
Segment by Application	Breast Cancer Lymphoma
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Antibody-drug Conjugates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody-drug Conjugates sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Antibody-drug Conjugates Market growing?

Ans: The Antibody-drug Conjugates Market witnessing a CAGR of 4.7 during the forecast period 2024-2030.

What is the Antibody-drug Conjugates Market size in 2030?

Ans: The Antibody-drug Conjugates Market size in 2030 will be US$ 3919.8 million.

What is the Antibody-drug Conjugates Market share by region?

Ans: Europe is follower, accounting for about 27% market share.

What is the Takeda share in Antibody-drug Conjugates Market?

Ans: Takeda is the largest manufacturer with about 57% revenue market share.

Who are the main players in the Antibody-drug Conjugates Market report?

Ans: The main players in the Antibody-drug Conjugates Market are Roche, Takeda

What are the Application segmentation covered in the Antibody-drug Conjugates Market report?

Ans: The Applications covered in the Antibody-drug Conjugates Market report are Breast Cancer, Lymphoma

What are the Type segmentation covered in the Antibody-drug Conjugates Market report?

Ans: The Types covered in the Antibody-drug Conjugates Market report are Adcetris, Kadcyla

1 Study Coverage

1.1 Antibody-drug Conjugates Product Introduction

1.2 Market by Type

1.2.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Adcetris

1.2.3 Kadcyla

1.3 Market by Application

1.3.1 Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Lymphoma

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts 2019-2030

2.2 Global Antibody-drug Conjugates Revenue by Region

2.2.1 Global Antibody-drug Conjugates Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Antibody-drug Conjugates Revenue by Region (2019-2024)

2.2.3 Global Antibody-drug Conjugates Revenue by Region (2025-2030)

2.2.4 Global Antibody-drug Conjugates Revenue Market Share by Region (2019-2030)

2.3 Global Antibody-drug Conjugates Sales Estimates and Forecasts 2019-2030

2.4 Global Antibody-drug Conjugates Sales by Region

2.4.1 Global Antibody-drug Conjugates Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Antibody-drug Conjugates Sales by Region (2019-2024)

2.4.3 Global Antibody-drug Conjugates Sales by Region (2025-2030)

2.4.4 Global Antibody-drug Conjugates Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Antibody-drug Conjugates Sales by Manufacturers

3.1.1 Global Antibody-drug Conjugates Sales by Manufacturers (2019-2024)

3.1.2 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibody-drug Conjugates in 2023

3.2 Global Antibody-drug Conjugates Revenue by Manufacturers

3.2.1 Global Antibody-drug Conjugates Revenue by Manufacturers (2019-2024)

3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Antibody-drug Conjugates Revenue in 2023

3.3 Global Key Players of Antibody-drug Conjugates, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Antibody-drug Conjugates Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Antibody-drug Conjugates, Product Offered and Application

3.8 Global Key Manufacturers of Antibody-drug Conjugates, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Antibody-drug Conjugates Sales by Type

4.1.1 Global Antibody-drug Conjugates Historical Sales by Type (2019-2024)

4.1.2 Global Antibody-drug Conjugates Forecasted Sales by Type (2025-2030)

4.1.3 Global Antibody-drug Conjugates Sales Market Share by Type (2019-2030)

4.2 Global Antibody-drug Conjugates Revenue by Type

4.2.1 Global Antibody-drug Conjugates Historical Revenue by Type (2019-2024)

4.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Type (2025-2030)

4.2.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)

4.3 Global Antibody-drug Conjugates Price by Type

4.3.1 Global Antibody-drug Conjugates Price by Type (2019-2024)

4.3.2 Global Antibody-drug Conjugates Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Antibody-drug Conjugates Sales by Application

5.1.1 Global Antibody-drug Conjugates Historical Sales by Application (2019-2024)

5.1.2 Global Antibody-drug Conjugates Forecasted Sales by Application (2025-2030)

5.1.3 Global Antibody-drug Conjugates Sales Market Share by Application (2019-2030)

5.2 Global Antibody-drug Conjugates Revenue by Application

5.2.1 Global Antibody-drug Conjugates Historical Revenue by Application (2019-2024)

5.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Application (2025-2030)

5.2.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)

5.3 Global Antibody-drug Conjugates Price by Application

5.3.1 Global Antibody-drug Conjugates Price by Application (2019-2024)

5.3.2 Global Antibody-drug Conjugates Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Antibody-drug Conjugates Market Size by Type

6.1.1 US & Canada Antibody-drug Conjugates Sales by Type (2019-2030)

6.1.2 US & Canada Antibody-drug Conjugates Revenue by Type (2019-2030)

6.2 US & Canada Antibody-drug Conjugates Market Size by Application

6.2.1 US & Canada Antibody-drug Conjugates Sales by Application (2019-2030)

6.2.2 US & Canada Antibody-drug Conjugates Revenue by Application (2019-2030)

6.3 US & Canada Antibody-drug Conjugates Market Size by Country

6.3.1 US & Canada Antibody-drug Conjugates Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Antibody-drug Conjugates Sales by Country (2019-2030)

6.3.3 US & Canada Antibody-drug Conjugates Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Antibody-drug Conjugates Market Size by Type

7.1.1 Europe Antibody-drug Conjugates Sales by Type (2019-2030)

7.1.2 Europe Antibody-drug Conjugates Revenue by Type (2019-2030)

7.2 Europe Antibody-drug Conjugates Market Size by Application

7.2.1 Europe Antibody-drug Conjugates Sales by Application (2019-2030)

7.2.2 Europe Antibody-drug Conjugates Revenue by Application (2019-2030)

7.3 Europe Antibody-drug Conjugates Market Size by Country

7.3.1 Europe Antibody-drug Conjugates Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Antibody-drug Conjugates Sales by Country (2019-2030)

7.3.3 Europe Antibody-drug Conjugates Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Antibody-drug Conjugates Market Size

8.1.1 China Antibody-drug Conjugates Sales (2019-2030)

8.1.2 China Antibody-drug Conjugates Revenue (2019-2030)

8.2 China Antibody-drug Conjugates Market Size by Application

8.2.1 China Antibody-drug Conjugates Sales by Application (2019-2030)

8.2.2 China Antibody-drug Conjugates Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Antibody-drug Conjugates Market Size by Type

9.1.1 Asia Antibody-drug Conjugates Sales by Type (2019-2030)

9.1.2 Asia Antibody-drug Conjugates Revenue by Type (2019-2030)

9.2 Asia Antibody-drug Conjugates Market Size by Application

9.2.1 Asia Antibody-drug Conjugates Sales by Application (2019-2030)

9.2.2 Asia Antibody-drug Conjugates Revenue by Application (2019-2030)

9.3 Asia Antibody-drug Conjugates Sales by Region

9.3.1 Asia Antibody-drug Conjugates Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Antibody-drug Conjugates Revenue by Region (2019-2030)

9.3.3 Asia Antibody-drug Conjugates Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Antibody-drug Conjugates Market Size by Type

10.1.1 Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Antibody-drug Conjugates Market Size by Application

10.2.1 Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Country

10.3.1 Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 ImmunoGen

11.1.1 ImmunoGen Company Information

11.1.2 ImmunoGen Overview

11.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 ImmunoGen Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 ImmunoGen Recent Developments

11.2 Seattle Genetics

11.2.1 Seattle Genetics Company Information

11.2.2 Seattle Genetics Overview

11.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Seattle Genetics Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Seattle Genetics Recent Developments

11.3 Roche

11.3.1 Roche Company Information

11.3.2 Roche Overview

11.3.3 Roche Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Roche Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Roche Recent Developments

11.4 Takeda

11.4.1 Takeda Company Information

11.4.2 Takeda Overview

11.4.3 Takeda Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Takeda Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Takeda Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Antibody-drug Conjugates Industry Chain Analysis

12.2 Antibody-drug Conjugates Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Antibody-drug Conjugates Production Mode & Process

12.4 Antibody-drug Conjugates Sales and Marketing

12.4.1 Antibody-drug Conjugates Sales Channels

12.4.2 Antibody-drug Conjugates Distributors

12.5 Antibody-drug Conjugates Customers

13 Market Dynamics

13.1 Antibody-drug Conjugates Industry Trends

13.2 Antibody-drug Conjugates Market Drivers

13.3 Antibody-drug Conjugates Market Challenges

13.4 Antibody-drug Conjugates Market Restraints

14 Key Findings in The Global Antibody-drug Conjugates Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Adcetris

Table 3. Major Manufacturers of Kadcyla

Table 4. Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Antibody-drug Conjugates Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Antibody-drug Conjugates Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Antibody-drug Conjugates Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Antibody-drug Conjugates Revenue Market Share by Region (2019-2024)

Table 9. Global Antibody-drug Conjugates Revenue Market Share by Region (2025-2030)

Table 10. Global Antibody-drug Conjugates Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Antibody-drug Conjugates Sales by Region (2019-2024) & (Kg)

Table 12. Global Antibody-drug Conjugates Sales by Region (2025-2030) & (Kg)

Table 13. Global Antibody-drug Conjugates Sales Market Share by Region (2019-2024)

Table 14. Global Antibody-drug Conjugates Sales Market Share by Region (2025-2030)

Table 15. Global Antibody-drug Conjugates Sales by Manufacturers (2019-2024) & (Kg)

Table 16. Global Antibody-drug Conjugates Sales Share by Manufacturers (2019-2024)

Table 17. Global Antibody-drug Conjugates Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Antibody-drug Conjugates, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Antibody-drug Conjugates Price by Manufacturers 2019-2024 (USD/Kg)

Table 21. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2023)

Table 23. Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Antibody-drug Conjugates, Product Offered and Application

Table 25. Global Key Manufacturers of Antibody-drug Conjugates, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Antibody-drug Conjugates Sales by Type (2019-2024) & (Kg)

Table 28. Global Antibody-drug Conjugates Sales by Type (2025-2030) & (Kg)

Table 29. Global Antibody-drug Conjugates Sales Share by Type (2019-2024)

Table 30. Global Antibody-drug Conjugates Sales Share by Type (2025-2030)

Table 31. Global Antibody-drug Conjugates Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Antibody-drug Conjugates Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Antibody-drug Conjugates Revenue Share by Type (2019-2024)

Table 34. Global Antibody-drug Conjugates Revenue Share by Type (2025-2030)

Table 35. Antibody-drug Conjugates Price by Type (2019-2024) & (USD/Kg)

Table 36. Global Antibody-drug Conjugates Price Forecast by Type (2025-2030) & (USD/Kg)

Table 37. Global Antibody-drug Conjugates Sales by Application (2019-2024) & (Kg)

Table 38. Global Antibody-drug Conjugates Sales by Application (2025-2030) & (Kg)

Table 39. Global Antibody-drug Conjugates Sales Share by Application (2019-2024)

Table 40. Global Antibody-drug Conjugates Sales Share by Application (2025-2030)

Table 41. Global Antibody-drug Conjugates Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Antibody-drug Conjugates Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Antibody-drug Conjugates Revenue Share by Application (2019-2024)

Table 44. Global Antibody-drug Conjugates Revenue Share by Application (2025-2030)

Table 45. Antibody-drug Conjugates Price by Application (2019-2024) & (USD/Kg)

Table 46. Global Antibody-drug Conjugates Price Forecast by Application (2025-2030) & (USD/Kg)

Table 47. US & Canada Antibody-drug Conjugates Sales by Type (2019-2024) & (Kg)

Table 48. US & Canada Antibody-drug Conjugates Sales by Type (2025-2030) & (Kg)

Table 49. US & Canada Antibody-drug Conjugates Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Antibody-drug Conjugates Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Antibody-drug Conjugates Sales by Application (2019-2024) & (Kg)

Table 52. US & Canada Antibody-drug Conjugates Sales by Application (2025-2030) & (Kg)

Table 53. US & Canada Antibody-drug Conjugates Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Antibody-drug Conjugates Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Antibody-drug Conjugates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Antibody-drug Conjugates Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Antibody-drug Conjugates Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Antibody-drug Conjugates Sales by Country (2019-2024) & (Kg)

Table 59. US & Canada Antibody-drug Conjugates Sales by Country (2025-2030) & (Kg)

Table 60. Europe Antibody-drug Conjugates Sales by Type (2019-2024) & (Kg)

Table 61. Europe Antibody-drug Conjugates Sales by Type (2025-2030) & (Kg)

Table 62. Europe Antibody-drug Conjugates Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Antibody-drug Conjugates Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Antibody-drug Conjugates Sales by Application (2019-2024) & (Kg)

Table 65. Europe Antibody-drug Conjugates Sales by Application (2025-2030) & (Kg)

Table 66. Europe Antibody-drug Conjugates Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Antibody-drug Conjugates Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Antibody-drug Conjugates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Antibody-drug Conjugates Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Antibody-drug Conjugates Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Antibody-drug Conjugates Sales by Country (2019-2024) & (Kg)

Table 72. Europe Antibody-drug Conjugates Sales by Country (2025-2030) & (Kg)

Table 73. China Antibody-drug Conjugates Sales by Type (2019-2024) & (Kg)

Table 74. China Antibody-drug Conjugates Sales by Type (2025-2030) & (Kg)

Table 75. China Antibody-drug Conjugates Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Antibody-drug Conjugates Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Antibody-drug Conjugates Sales by Application (2019-2024) & (Kg)

Table 78. China Antibody-drug Conjugates Sales by Application (2025-2030) & (Kg)

Table 79. China Antibody-drug Conjugates Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Antibody-drug Conjugates Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Antibody-drug Conjugates Sales by Type (2019-2024) & (Kg)

Table 82. Asia Antibody-drug Conjugates Sales by Type (2025-2030) & (Kg)

Table 83. Asia Antibody-drug Conjugates Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Antibody-drug Conjugates Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Antibody-drug Conjugates Sales by Application (2019-2024) & (Kg)

Table 86. Asia Antibody-drug Conjugates Sales by Application (2025-2030) & (Kg)

Table 87. Asia Antibody-drug Conjugates Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Antibody-drug Conjugates Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Antibody-drug Conjugates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Antibody-drug Conjugates Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Antibody-drug Conjugates Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Antibody-drug Conjugates Sales by Region (2019-2024) & (Kg)

Table 93. Asia Antibody-drug Conjugates Sales by Region (2025-2030) & (Kg)

Table 94. Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Type (2019-2024) & (Kg)

Table 95. Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Type (2025-2030) & (Kg)

Table 96. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Application (2019-2024) & (Kg)

Table 99. Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Application (2025-2030) & (Kg)

Table 100. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Country (2019-2024) & (Kg)

Table 106. Middle East, Africa and Latin America Antibody-drug Conjugates Sales by Country (2025-2030) & (Kg)

Table 107. ImmunoGen Company Information

Table 108. ImmunoGen Description and Major Businesses

Table 109. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 110. ImmunoGen Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. ImmunoGen Recent Developments

Table 112. Seattle Genetics Company Information

Table 113. Seattle Genetics Description and Major Businesses

Table 114. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 115. Seattle Genetics Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Seattle Genetics Recent Developments

Table 117. Roche Company Information

Table 118. Roche Description and Major Businesses

Table 119. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 120. Roche Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Roche Recent Developments

Table 122. Takeda Company Information

Table 123. Takeda Description and Major Businesses

Table 124. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 125. Takeda Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Takeda Recent Developments

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Antibody-drug Conjugates Distributors List

Table 130. Antibody-drug Conjugates Customers List

Table 131. Antibody-drug Conjugates Market Trends

Table 132. Antibody-drug Conjugates Market Drivers

Table 133. Antibody-drug Conjugates Market Challenges

Table 134. Antibody-drug Conjugates Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Antibody-drug Conjugates Product Picture

Figure 2. Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Antibody-drug Conjugates Market Share by Type in 2023 & 2030

Figure 4. Adcetris Product Picture

Figure 5. Kadcyla Product Picture

Figure 6. Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Antibody-drug Conjugates Market Share by Application in 2023 & 2030

Figure 8. Breast Cancer

Figure 9. Lymphoma

Figure 10. Antibody-drug Conjugates Report Years Considered

Figure 11. Global Antibody-drug Conjugates Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Antibody-drug Conjugates Revenue 2019-2030 (US$ Million)

Figure 13. Global Antibody-drug Conjugates Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Antibody-drug Conjugates Revenue Market Share by Region (2019-2030)

Figure 15. Global Antibody-drug Conjugates Sales 2019-2030 ((Kg)

Figure 16. Global Antibody-drug Conjugates Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Antibody-drug Conjugates Sales YoY (2019-2030) & (Kg)

Figure 18. US & Canada Antibody-drug Conjugates Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Antibody-drug Conjugates Sales YoY (2019-2030) & (Kg)

Figure 20. Europe Antibody-drug Conjugates Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Antibody-drug Conjugates Sales YoY (2019-2030) & (Kg)

Figure 22. China Antibody-drug Conjugates Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Antibody-drug Conjugates Sales YoY (2019-2030) & (Kg)

Figure 24. Asia (excluding China) Antibody-drug Conjugates Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Antibody-drug Conjugates Sales YoY (2019-2030) & (Kg)

Figure 26. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Antibody-drug Conjugates Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Antibody-drug Conjugates in the World: Market Share by Antibody-drug Conjugates Revenue in 2023

Figure 29. Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Antibody-drug Conjugates Sales Market Share by Type (2019-2030)

Figure 31. Global Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)

Figure 32. Global Antibody-drug Conjugates Sales Market Share by Application (2019-2030)

Figure 33. Global Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Antibody-drug Conjugates Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Antibody-drug Conjugates Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Antibody-drug Conjugates Revenue Share by Country (2019-2030)

Figure 39. US & Canada Antibody-drug Conjugates Sales Share by Country (2019-2030)

Figure 40. U.S. Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Antibody-drug Conjugates Sales Market Share by Type (2019-2030)

Figure 43. Europe Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)

Figure 44. Europe Antibody-drug Conjugates Sales Market Share by Application (2019-2030)

Figure 45. Europe Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)

Figure 46. Europe Antibody-drug Conjugates Revenue Share by Country (2019-2030)

Figure 47. Europe Antibody-drug Conjugates Sales Share by Country (2019-2030)

Figure 48. Germany Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 49. France Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 53. China Antibody-drug Conjugates Sales Market Share by Type (2019-2030)

Figure 54. China Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)

Figure 55. China Antibody-drug Conjugates Sales Market Share by Application (2019-2030)

Figure 56. China Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)

Figure 57. Asia Antibody-drug Conjugates Sales Market Share by Type (2019-2030)

Figure 58. Asia Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)

Figure 59. Asia Antibody-drug Conjugates Sales Market Share by Application (2019-2030)

Figure 60. Asia Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)

Figure 61. Asia Antibody-drug Conjugates Revenue Share by Region (2019-2030)

Figure 62. Asia Antibody-drug Conjugates Sales Share by Region (2019-2030)

Figure 63. Japan Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 67. India Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Antibody-drug Conjugates Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Antibody-drug Conjugates Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Antibody-drug Conjugates Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Antibody-drug Conjugates Sales Share by Country (2019-2030)

Figure 74. Brazil Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Antibody-drug Conjugates Revenue (2019-2030) & (US$ Million)

Figure 79. Antibody-drug Conjugates Value Chain

Figure 80. Antibody-drug Conjugates Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23Z18292

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14Z15017

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7M18883

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37J14968

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions